Driving Precision Delivery & Scalable Manufacturing for The Next Wave of Exosome-Based Therapeutics

As landmark clinical programs from pioneers including RION and Capricor Therapeutics progress beyond early-stage development, the exosome therapeutics field is entering a transformative era. Growing clinical validation, expanding therapeutic applications, and increasing investor confidence are accelerating exosomes from a promising modality to a commercially viable therapeutic platform. With regulatory scrutiny rising and development complexity increasing, the industry faces a critical opportunity to establish the manufacturing, analytical, and clinical foundations needed to bring exosome-based medicines to patients at scale.

Bringing together experts across Discovery & Translational Science, CMC & Manufacturing, Analytical Development, Clinical Development, Regulatory Affairs, Quality & Commercial Strategy, the 8th Exosome-Based Therapeutics Summit will provide end-to-end insights needed to de-risk development, accelerate clinical progress, and build commercially sustainable exosome therapies.

Uniting senior leaders from pioneering biotech innovators, emerging start-ups, technology enablers, manufacturers, investors, and regulatory stakeholders, this meeting is where the exosome community comes together to overcome today's bottlenecks and define tomorrow's standards.

If you are serious about advancing exosome therapeutics toward approval and commercial success, this is where you need to be.